论文部分内容阅读
美国学者进行的一项系统评价比较了在动脉粥样硬化性心血管疾病(ASCVD)高危风险人群中低强度他汀类药物联合非他汀类降脂药和高强度他汀类药物单一治疗的临床获益、依从性和危害。结果显示,低强度他汀加其他降
A systematic review by American scholars compared the clinical benefits of monotherapy with low-intensity statins with non-statin lipid-lowering drugs and high-intensity statin in people at high risk of atherosclerotic cardiovascular disease (ASCVD) Compliance and Hazard. The results showed that low-intensity statins plus other drops